N.J. Admin. Code § 8:65-1.2

Current through Register Vol. 56, No. 9, May 6, 2024

Section 8:65-1.2 - Publications incorporated by reference

(a) The following web-based publications of, or administered by, the United States Department of Health and Human Services, are incorporated herein by reference, as amended and supplemented:

1. CDC, Revised Surveillance Case Definition for HIV Infection -- United States, 2014, MMWR 2014; 63 (No. RR-3) (April 11, 2014) (hereinafter referred to as "surveillance case definition"), available at http://www.cdc.gov/mmwr/pdf/rr/rr6303.pdf, http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6303a1.htm, and http://www.cdc.gov/hiv/guidelines/reporting.html;

2. CDC, Data Security and Confidentiality Guidelines for HIV, Viral Hepatitis, Sexually Transmitted Disease, and Tuberculosis Programs: Standards to Facilitate Sharing and Use of Surveillance Data for Public Health Action (2011) (hereinafter referred to as the "Data Security Guidelines"), available at http://www.cdc.gov/hiv/guidelines/reporting.html and http://www.cdc.gov/nchhstp/programintegration/docs/pcsidatasecurityguidelines.pdf;

3. CDC, HIV Diagnostic Tests LOINC Map (2021), available at http://www.cdc.gov/hiv/guidelines/reporting.html;

4. CDC, National Center for Health Statistics, under authorization by the World Health Organization, International Statistical Classification of Diseases and Related Health Problems, 10th revision, Clinical Modification (2021 release) (hereinafter referred to as the "ICD-10-CM,") available at http://www.cdc.gov/nchs/icd/icd10cm.htm;

5. CDC and Association of Public Health Laboratories, Laboratory Testing for the Diagnosis of HIV Infection: Updated Recommendations (June 27, 2014) (hereinafter referred to as the "Laboratory Testing Recommendations"), available at http://dx.doi.org/10.15620/cdc.23447; and

6. CDC, 2018 Quick reference guide: Recommended laboratory HIV testing algorithm for serum or plasma specimens (2018) (hereinafter referred to as the "testing algorithm"), available at http://stacks.cdc.gov/view/cdc/50872.

(b) The following web-based publications of, or administered by, the Veterans Health Administration (VHA) of the United States Department of Veterans Affairs (VA) are incorporated herein by reference, as amended and supplemented:

1. VHA Directive 1131(4), Management of Infectious Diseases and Infection Prevention and Control Programs (November 7, 2017, amended March 26, 2021) (hereinafter referred to as "VHA Directive 1131(4)"), available at http://www.va.gov/vhapublications/ViewPublication.asp?pub_ID=5616 (see, particularly, Appendix E Infectious Disease Reporting ); and

2. VHA Directive 1304, National Human Immunodeficiency Virus (HIV) Program (August 15, 2019) (hereinafter referred to as "VHA Directive 1304") available at http://www.va.gov/vhapublications/ViewPublication.asp?pub_ID=3056 (see, particularly, Part 5, Responsibilities, §f VA Medical Facility Director, at subsection (11)).

(c) The following web-based publications of, or administered by, the Federal Bureau of Prisons (BOP) of the United States Department of Justice are incorporated herein by reference, as amended and supplemented:

1. BOP, Clinical Guidance: HIV Management (April 2021) (hereinafter referred to as BOP HIV Management Guidance, available at http://www.bop.gov/resources/pdfs/hiv_infection_management_20210427.pdf, and

2. BOP, Program Statement Number 6190.04, Infectious Disease Management (June 3, 2014) (hereinafter referred to as "BOP PS 6190.04") available at http://www.bop.gov/policy/progstat/6190_004.pdf.

N.J. Admin. Code § 8:65-1.2

Adopted by 54 N.J.R. 1408(a), effective 7/18/2022